Franklin Templeton India’s Hari Shyamsunder suggests a range-bound market, noting India’s rally alongside global markets. While large-cap valuations are stretched, mid and small-caps offer growth opportunities. He favors consumption-related sectors like hotels and retail, anticipating a boost from monetary and fiscal policies, while remaining cautious on capex due to high valuations.
Dr Reddy’s, Sun Pharma and other pharma stocks fall up to 3% as Trump threatens 25% tariff on India
Indian pharma stocks fell up to 3% after U.S. President Trump announced a 25% tariff on Indian imports over its trade with Russia. Concerns rose